New Enterprise Associates 16, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001694560. 10% Owner at Trevi Therapeutics, Inc. (TRVI) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2025. Located in TIMONIUM, MD.
Companies New Enterprise Associates 16, L.P. has filed insider reports for
- Trevi Therapeutics, Inc. (TRVI): 10% Owner
- NeueHealth, Inc. (NEUE): 10% Owner
- Marker Therapeutics, Inc. (MRKR): 10% Owner
New Enterprise Associates 16, L.P.
CIK: 0001694560
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Oct 2, 2025NEUE
NeueHealth, Inc.
AwardDirectWarrant (Right to Buy)
372.3K shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
ExerciseDirect372.3K shares at avg. $0.01$4K - Oct 2, 2025NEUE
NeueHealth, Inc.
Tax PaymentDirect551 shares at avg. $6.75$4K - Oct 2, 2025NEUE
NeueHealth, Inc.
DispositionDirect1.2M shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
In-the-MoneyDirect189.2K shares at avg. $0.01$2K - Oct 2, 2025NEUE
NeueHealth, Inc.
SaleDirect280 shares at avg. $6.75$2K - Apr 17, 2025TRVI
Trevi Therapeutics, Inc.
In-the-MoneyDirect1.9M shares at avg. $1.37$2.5M - Dec 23, 2024MRKR
Marker Therapeutics, Inc.
PurchaseDirect554.3K shares at avg. $3.20$1.8M - Oct 1, 2024NEUE
NeueHealth, Inc.
PurchaseDirectWarrant (Right to Buy)
61.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2025 |  NEUE NeueHealth, Inc. | Award Warrant (Right to Buy) | 372,255 | - | - | Direct |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Exercise | 372,255 | $0.01 | $3,723 | Direct |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Tax Payment | 551 | $6.75 | $3,719 | Direct |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Disposition | 1,159,683 | - | - | Direct |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | In-the-Money | 189,195 | $0.01 | $1,892 | Direct |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Sale | 280 | $6.75 | $1,890 | Direct |
| Apr 17, 2025 |  TRVI Trevi Therapeutics, Inc. | In-the-Money | 1,851,852 | $1.37 | $2,537,037 | Direct |
| Dec 23, 2024 |  MRKR Marker Therapeutics, Inc. | Purchase | 554,250 | $3.20 | $1,773,600 | Direct |
| Oct 1, 2024 | NEUE NeueHealth, Inc. | Purchase Warrant (Right to Buy) | 61,865 | - | - | Direct |
1-9 of 9 transactions